effect enteric-co aspirin morn increas platelet activ vitro platelet aggreg diphosph adp epinephrin increas morn frequenc myocardi infarct single-blind cross-ov studi healthi male measur platelet activ morn increas aspirin increas platelet activ subject mg enteric-co aspirin eca placebo placebo therapi platelet thromboxan product collagen stimul subject aggreg adp epinephrin collagen eca baselin platelet thromboxan product increas subject biphas aggreg respons adp morn increas aggreg agent collagen lag time synergist aggreg agonist effect day increas tissu plasminogen activ subject aris aspirin prevent myocardi infarct antiplatelet action like preferenti reduct morn infarct health studi demonstr aspirin morn increas platelet activ morn increas myocardi infarct due part concurr modest increas platelet activ 